SCHEMBL15711352

SCHEMBL15711352

O=[N+]([O-])C1=C(F)C=CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15003547 0.75
SCHEMBL11203642 0.75 ALDH1A1 (0.30)
SCHEMBL30349823 0.75 ALDH1A1 (0.32)
SCHEMBL18434778 0.71
SCHEMBL30349850 0.71 ALDH1A1 (0.32)
SCHEMBL19308518 0.71
SCHEMBL20977414 0.71
SCHEMBL8312472 0.69 ALDH1A1 (0.35)
SCHEMBL24488665 0.68
SCHEMBL20977296 0.68 LMNA (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115867277-A Novel fused heterocyclyl-carbohydrazone acyldinitrile compounds and use thereof 韩国科学技术研究院 2023-03-28 CN disclosed
EP-2114948-B1 INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE ABBVIE INC (US) 2014-06-25 EP disclosed
EP-2336122-B1 1-PYRIMIDINYL- OR 1-PYRIDINYL-2-AMINO BENZIMIDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES FOR THE TREATMENT OF CANCER VERTEX PHARMA (US) 2014-05-14 EP disclosed